How Long Until GLP-1 Medications Suppress Appetite?

Most patients notice reduced appetite within 1-2 weeks of their first GLP-1 injection. The appetite-suppressing effect is mild at the starting dose and strengthens progressively with each dose increase during the titration period. Full appetite suppression typically develops over 4-8 weeks as the medication builds to therapeutic levels in your bloodstream.

Appetite Suppression Timeline by Medication

Semaglutide (Ozempic, Wegovy)

• Week 1-2 (0.25 mg): Mild appetite reduction. Some patients notice feeling full sooner at meals. Others feel little change.
• Week 3-4 (0.25-0.5 mg): More consistent appetite reduction as the drug approaches steady state at this dose level.
• Week 5-8 (0.5-1.0 mg): Noticeable, reliable appetite suppression. Most patients describe a fundamentally different relationship with hunger.
• Week 9+ (1.0-2.4 mg): Strong appetite suppression. Many patients describe having to remind themselves to eat.

Tirzepatide (Mounjaro, Zepbound)

• Week 1-2 (2.5 mg): Mild appetite effects, similar to low-dose semaglutide.
• Week 3-4 (2.5-5 mg): Appetite reduction becomes more apparent. The dual GIP/GLP-1 action may produce effects faster for some patients.
• Week 5-8 (5-10 mg): Significant appetite suppression. Many patients report stronger effects than they experienced with semaglutide at comparable treatment stages.
• Week 9+ (10-15 mg): Maximum appetite suppression at the full dose.

How GLP-1 Medications Suppress Appetite

GLP-1 medications reduce appetite through multiple complementary mechanisms:

• Hypothalamic signaling: GLP-1 receptors in the brain's appetite control centers (hypothalamus and brainstem) are activated, reducing hunger signals.
• Delayed gastric emptying: Food stays in the stomach longer, prolonging the feeling of fullness after meals.
• Reward pathway modulation: GLP-1 medications reduce the dopamine-driven reward response to food, decreasing cravings and food-seeking behavior.
• Satiety hormone enhancement: The medication amplifies your body's natural "I'm full" signals.

What If You Don't Feel Appetite Suppression?

• Be patient with titration: The starting dose is intentionally low. Most patients do not feel significant effects until 0.5-1.0 mg semaglutide or 5-7.5 mg tirzepatide.
• Wait for steady state: It takes 4-5 weeks at any given dose for the drug to reach consistent blood levels.
• Track your intake objectively: Some patients do not perceive appetite reduction but are actually eating less when they track food intake.
• Discuss with your provider: If you have been at 1.7 mg semaglutide or 10 mg tirzepatide for 8+ weeks with no effect, your provider may evaluate whether the medication is appropriate for you.

Frequently Asked Questions

How long until GLP-1 medications suppress appetite?

Most patients notice mild appetite reduction within 1-2 weeks. Full appetite suppression develops over 4-8 weeks as doses increase during titration.

Which GLP-1 suppresses appetite faster?

Tirzepatide may produce slightly faster appetite suppression due to its dual receptor action, but individual responses vary. Both medications follow gradual titration schedules.

What if I don't feel appetite suppression on my GLP-1?

Starting doses are intentionally sub-therapeutic. Give the titration process at least 8-12 weeks. Most patients feel significant effects at moderate doses and above.

Start your GLP-1 journey with expert titration support. Explore Trimi's treatment programs.